regency medicine ltd. Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
3 castle court, carnegie campus, dunfermline, fife, KY11 8PB
Website
gemhealth.comregency medicine ltd. Estimated Valuation
Pomanda estimates the enterprise value of REGENCY MEDICINE LTD. at £2m based on a Turnover of £4.3m and 0.48x industry multiple (adjusted for size and gross margin).
regency medicine ltd. Estimated Valuation
Pomanda estimates the enterprise value of REGENCY MEDICINE LTD. at £486.2k based on an EBITDA of £133.1k and a 3.65x industry multiple (adjusted for size and gross margin).
regency medicine ltd. Estimated Valuation
Pomanda estimates the enterprise value of REGENCY MEDICINE LTD. at £4.9m based on Net Assets of £1.9m and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Regency Medicine Ltd. Overview
Regency Medicine Ltd. is a live company located in dunfermline, KY11 8PB with a Companies House number of SC189762. It operates in the other human health activities sector, SIC Code 86900. Founded in September 1998, it's largest shareholder is gem care 1 ltd with a 100% stake. Regency Medicine Ltd. is a mature, small sized company, Pomanda has estimated its turnover at £4.3m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Regency Medicine Ltd. Health Check
Pomanda's financial health check has awarded Regency Medicine Ltd. a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
6 Weak
Size
annual sales of £4.3m, make it larger than the average company (£652.6k)
- Regency Medicine Ltd.
£652.6k - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (6%)
- Regency Medicine Ltd.
6% - Industry AVG
Production
with a gross margin of 21.9%, this company has a higher cost of product (38.9%)
- Regency Medicine Ltd.
38.9% - Industry AVG
Profitability
an operating margin of 2.4% make it less profitable than the average company (5.5%)
- Regency Medicine Ltd.
5.5% - Industry AVG
Employees
with 47 employees, this is above the industry average (17)
47 - Regency Medicine Ltd.
17 - Industry AVG
Pay Structure
on an average salary of £26k, the company has an equivalent pay structure (£26k)
- Regency Medicine Ltd.
£26k - Industry AVG
Efficiency
resulting in sales per employee of £90.4k, this is more efficient (£48.3k)
- Regency Medicine Ltd.
£48.3k - Industry AVG
Debtor Days
it gets paid by customers after 133 days, this is later than average (23 days)
- Regency Medicine Ltd.
23 days - Industry AVG
Creditor Days
its suppliers are paid after 14 days, this is quicker than average (19 days)
- Regency Medicine Ltd.
19 days - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (15 days)
- Regency Medicine Ltd.
15 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 22 weeks, this is less cash available to meet short term requirements (112 weeks)
22 weeks - Regency Medicine Ltd.
112 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.3%, this is a lower level of debt than the average (26.6%)
12.3% - Regency Medicine Ltd.
26.6% - Industry AVG
REGENCY MEDICINE LTD. financials
Regency Medicine Ltd.'s latest turnover from October 2023 is estimated at £4.3 million and the company has net assets of £1.9 million. According to their latest financial statements, Regency Medicine Ltd. has 47 employees and maintains cash reserves of £58.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 47 | 46 | 46 | 46 | 48 | 43 | 49 | 49 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 611,465 | 628,531 | 652,304 | 679,042 | 690,586 | 710,498 | 722,335 | 737,046 | 750,157 | 770,350 | 791,653 | 800,886 | 822,216 | 840,516 | 864,219 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 611,465 | 628,531 | 652,304 | 679,042 | 690,586 | 710,498 | 722,335 | 737,046 | 750,157 | 770,350 | 791,653 | 800,886 | 822,216 | 840,516 | 864,219 |
Stock & work in progress | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,198 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 950 | 950 |
Trade Debtors | 1,551,108 | 1,479,895 | 1,326,481 | 1,380,503 | 881,830 | 833,221 | 841,908 | 698,597 | 548,589 | 329,335 | 293,837 | 15,605 | 39,518 | 625,525 | 415,079 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 58,409 | 32,050 | 73,189 | 6,413 | 58,470 | 12,062 | 13,376 | 32,248 | 16,744 | 60,805 | 8,852 | 180,351 | 49,739 | 473,097 | 334,708 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 370 | 0 | 0 | 0 |
total current assets | 1,612,517 | 1,514,945 | 1,402,670 | 1,389,916 | 943,300 | 848,283 | 858,482 | 733,845 | 568,333 | 393,140 | 305,689 | 199,326 | 92,257 | 1,099,572 | 750,737 |
total assets | 2,223,982 | 2,143,476 | 2,054,974 | 2,068,958 | 1,633,886 | 1,558,781 | 1,580,817 | 1,470,891 | 1,318,490 | 1,163,490 | 1,097,342 | 1,000,212 | 914,473 | 1,940,088 | 1,614,956 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 134,740 | 87,272 | 78,187 | 115,434 | 87,281 | 87,396 | 101,204 | 113,501 | 121,166 | 112,062 | 126,592 | 119,831 | 110,442 | 166,862 | 115,082 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 134,740 | 87,272 | 78,187 | 115,434 | 87,281 | 87,396 | 101,204 | 113,501 | 121,166 | 112,062 | 126,592 | 119,831 | 110,442 | 166,862 | 115,082 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 117,424 | 162,879 | 208,333 | 250,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 307,241 | 332,303 |
provisions | 21,933 | 21,933 | 21,933 | 21,933 | 21,933 | 21,933 | 21,933 | 21,933 | 20,493 | 20,401 | 20,889 | 17,981 | 17,770 | 17,551 | 17,326 |
total long term liabilities | 139,357 | 184,812 | 230,266 | 271,933 | 21,933 | 21,933 | 21,933 | 21,933 | 20,493 | 20,401 | 20,889 | 17,981 | 17,770 | 324,792 | 349,629 |
total liabilities | 274,097 | 272,084 | 308,453 | 387,367 | 109,214 | 109,329 | 123,137 | 135,434 | 141,659 | 132,463 | 147,481 | 137,812 | 128,212 | 491,654 | 464,711 |
net assets | 1,949,885 | 1,871,392 | 1,746,521 | 1,681,591 | 1,524,672 | 1,449,452 | 1,457,680 | 1,335,457 | 1,176,831 | 1,031,027 | 949,861 | 862,400 | 786,261 | 1,448,434 | 1,150,245 |
total shareholders funds | 1,949,885 | 1,871,392 | 1,746,521 | 1,681,591 | 1,524,672 | 1,449,452 | 1,457,680 | 1,335,457 | 1,176,831 | 1,031,027 | 949,861 | 862,400 | 786,261 | 1,448,434 | 1,150,245 |
Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 30,774 | 29,907 | 31,456 | 34,073 | 32,627 | 34,250 | 31,161 | 32,780 | 30,163 | 29,907 | 3,021 | 26,112 | 26,236 | 25,348 | 26,261 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | |||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | -198 | 198 | 0 | 0 | 0 | 0 | 0 | 2,050 | 0 | 950 |
Debtors | 71,213 | 153,414 | -54,022 | 498,673 | 48,609 | -8,687 | 143,311 | 150,008 | 219,254 | 35,498 | 278,232 | -23,913 | -586,007 | 210,446 | 415,079 |
Creditors | 47,468 | 9,085 | -37,247 | 28,153 | -115 | -13,808 | -12,297 | -7,665 | 9,104 | -14,530 | 6,761 | 9,389 | -56,420 | 51,780 | 115,082 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,440 | 92 | -488 | 2,908 | 211 | 219 | 225 | 17,326 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | -45,455 | -45,454 | -41,667 | 250,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -307,241 | -25,062 | 332,303 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 26,359 | -41,139 | 66,776 | -52,057 | 46,408 | -1,314 | -18,872 | 15,504 | -44,061 | 51,953 | -171,499 | 130,612 | -423,358 | 138,389 | 334,708 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 26,359 | -41,139 | 66,776 | -52,057 | 46,408 | -1,314 | -18,872 | 15,504 | -44,061 | 51,953 | -171,499 | 130,612 | -423,358 | 138,389 | 334,708 |
regency medicine ltd. Credit Report and Business Information
Regency Medicine Ltd. Competitor Analysis
Perform a competitor analysis for regency medicine ltd. by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in KY11 area or any other competitors across 12 key performance metrics.
regency medicine ltd. Ownership
REGENCY MEDICINE LTD. group structure
Regency Medicine Ltd. has no subsidiary companies.
regency medicine ltd. directors
Regency Medicine Ltd. currently has 1 director, Mr Mahendran Bakeirathan serving since Apr 2011.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Mahendran Bakeirathan | England | 50 years | Apr 2011 | - | Director |
P&L
October 2023turnover
4.3m
+12%
operating profit
102.3k
0%
gross margin
22%
+1.3%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
October 2023net assets
1.9m
+0.04%
total assets
2.2m
+0.04%
cash
58.4k
+0.82%
net assets
Total assets minus all liabilities
regency medicine ltd. company details
company number
SC189762
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
September 1998
age
27
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
October 2023
previous names
N/A
accountant
-
auditor
-
address
3 castle court, carnegie campus, dunfermline, fife, KY11 8PB
Bank
-
Legal Advisor
-
regency medicine ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to regency medicine ltd.. Currently there are 3 open charges and 1 have been satisfied in the past.
regency medicine ltd. Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for REGENCY MEDICINE LTD.. This can take several minutes, an email will notify you when this has completed.
regency medicine ltd. Companies House Filings - See Documents
date | description | view/download |
---|